Bas Vorsteveld

Kenvue appoints Bas Vorsteveld as Managing Director for Northern Europe

Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the UK, Ireland, Norway, Sweden, Denmark and Finland.

Bas will manage a portfolio of iconic brands including Nicorette, Aveeno, Johnson’s Baby, Listerine, Neutrogena, Calpol, OGX and Imodium.

Carlton Lawson, Group President for Europe, Middle East, Africa and Latin America at Kenvue, said: “We are excited to welcome Bas as Area Managing Director for Kenvue in Northern Europe. With almost three decades of experience in consumer goods and healthcare, Bas brings a proven track record of delivering industry leading growth.”

Bas said: “Kenvue’s iconic brands speak for themselves. I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in.”

Prior to joining Kenvue, Bas held the position of Vice President & General Manager for Great Britain and Ireland at Haleon. He played a critical role in driving the GBI business, separating it from GSK while delivering industry-leading growth.

Bas was until recently President of the Board of the PAGB. He launched the organisation’s five-year strategy focusing on how the industry can support the government in alleviating healthcare pressures through promoting self-care.

Previously, Bas held several roles across Europe with GSK Consumer Healthcare, including VP & Head of Commercial Excellence EMEA, VP & General Manager France and French-speaking Africa & Maghreb, and GM Benelux. Prior to that, he held GM roles at Novartis. Bas started his career at Campina.